170 related articles for article (PubMed ID: 19351725)
1. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.
Bollerslev J; Rosen T; Mollerup CL; Nordenström J; Baranowski M; Franco C; Pernow Y; Isaksen GA; Godang K; Ueland T; Jansson S;
J Clin Endocrinol Metab; 2009 Jul; 94(7):2255-61. PubMed ID: 19351725
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
3. Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism.
Persson A; Bollerslev J; Rosen T; Mollerup CL; Franco C; Isaksen GA; Ueland T; Jansson S; Caidahl K;
Clin Endocrinol (Oxf); 2011 Feb; 74(2):174-80. PubMed ID: 21044114
[TBL] [Abstract][Full Text] [Related]
4. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
[TBL] [Abstract][Full Text] [Related]
5. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.
Rubin MR; Bilezikian JP; McMahon DJ; Jacobs T; Shane E; Siris E; Udesky J; Silverberg SJ
J Clin Endocrinol Metab; 2008 Sep; 93(9):3462-70. PubMed ID: 18544625
[TBL] [Abstract][Full Text] [Related]
6. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.
Sankaran S; Gamble G; Bolland M; Reid IR; Grey A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1653-62. PubMed ID: 20130069
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
11. Mild primary hyperparathyroidism: a literature review.
Applewhite MK; Schneider DF
Oncologist; 2014 Sep; 19(9):919-29. PubMed ID: 25063228
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
13. Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism.
de Luis DA; Soto GD; Conde R; Izaola O; de la Fuente B
J Clin Lab Anal; 2012 Sep; 26(5):398-402. PubMed ID: 23001986
[TBL] [Abstract][Full Text] [Related]
14. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.
Bollerslev J; Jansson S; Mollerup CL; Nordenström J; Lundgren E; Tørring O; Varhaug JE; Baranowski M; Aanderud S; Franco C; Freyschuss B; Isaksen GA; Ueland T; Rosen T
J Clin Endocrinol Metab; 2007 May; 92(5):1687-92. PubMed ID: 17284629
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
17. Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.
Caldwell M; Laux J; Clark M; Kim L; Rubin J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4473-4480. PubMed ID: 31188435
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
20. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
